Skip to main content

Table 1 HIV prevalence and incidence of women participating in trials in KwaZulu-Natal, and overall trial outcome.

From: Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa

Trial
(total enrolment)
Years Location of HPRU sites
(no. enrolled)
HIV prevalence (%) HIV incidence
(/100 woman years)
Overall outcome of trial: HR (95% CI)
MIRA
(5045)
2003-2006 Durban
(1515)
39 6.8 1.05
(0.84-1.32) P = 0.65
Carraguard
(6202)
2004-2007 Durban
(1485)
43 6 0.87
(0.69-1.09) P = 0.302
Cellulose sulphate
(1428)
2006-2007 Durban
(606)
51 5.29 1.61
(0.86-3.01) P = 0.13
HPTN 035
(3101)
2005-2008 Durban (702)
Hlabisa (346)
21.6
28.2
4.6
9.1
0.71
(0.46-1.11) P = 0.1331
MDP 301
(9385)
2005-2009 Durban
(2392)
36 6.1 1.05
(0.82-1.34) P = 0.712
  1. HR = Hazard ratio